Causes, Not Just Cases® | The Motley Rice Law Blog

Filter By

Clear Filters

April 2, 2020

Childhood sexual abuse litigation FAQ: “Lookback window” laws give voice to victims

1 in 4 girls and 1 in 6 boys will suffer sexual abuse by an adult before they turn 18, according to the National Sexual Violence Resource Center. For many, their abuse is a secret that weighs heavily, well into adulthood, even as abusers walk free and the institutions that enabled the abuse are not held accountable. New “lookback window” laws enacted in several states throughout the country seek to give adult victims of childhood sexual abuse a stronger voice and an opportunity to hold their abusers and abuse enablers accountable in civil court.

Read More

March 19, 2020

Proposed CFPB whistleblower program a plus for consumers

Recognizing the success of the SEC and CFTC whistleblower programs, the Consumer Financial Protection Bureau recently proposed that Congress amend the Dodd-Frank Act to add a whistleblower program that rewards whistleblowers who provide information regarding possible consumer protection law violations.

Read More

February 26, 2020

Decade in Review: Plaintiffs’ Litigation Highlights

2010-2019 taught all of us a great deal, and changes over the course of the decade shape the way we practice law today. Advancements in technology modernized the judiciary and have helped to expedite certain parts of the litigation process, such as discovery. The speed in which information is shared online would have been unfathomable when Ron Motley and I first started litigating asbestos cases.

Read More

February 14, 2020

SEC’s proposed rules are bad news for whistleblowers

Proposed amendments to the Securities and Exchange Commission’s whistleblower program rules include expanding the types of resolutions covered by the program, giving the SEC discretion in modifying awards, eliminating potential double recovery, adjusting the claims review process, and barring individuals who submit false information or make repeated frivolous claims.

Read More

December 3, 2019

SEC whistleblower office reports another promising year, reaffirms commitment to whistleblower protection and enforcement actions

Eight years after its inception, the SEC’s Whistleblower Program continues to have a significant, positive impact in protecting not only whistleblowers, but investors, markets and by extension, the public. In addition, the Whistleblower Program allows the SEC to bring enforcement actions in considerably less time, using fewer resources.

Read More

November 12, 2019

Dangerous vehicle defects may put millions of Americans at risk

We put a lot of faith in auto manufacturers. As our vehicles become loaded with technological advancements, we have trust the manufacturers have installed these features to help protect us. We often assume that manufacturers tested and vetted this technology appropriately. And, we trust these features will actually work as intended and save us from harm during an accident. But are we too quick to make this assumption?

Read More

October 1, 2019

Asbestos is still a threat

As Mesothelioma Awareness Month comes to an end, I am often reminded that asbestos remains a constant threat. Take the news from just last month that several top aides were evacuated from the White House so that asbestos could be removed from the ceilings and attic spaces in the West Wing’s second floor. The U.S. General Services Administration described this as a mere “precautionary measure,” but I think that’s putting it mildly as asbestos is a dangerous, deadly carcinogen.

Read More

August 19, 2019

FDA’s push for transparency long overdue

Generally speaking, manufacturers are required to submit individual reports to the FDA for each patient who sustains an injury or complication caused by a medical product. Established in 1997, Alternative Summary Reporting Program allowed manufacturers to bypass that standard by submitting quarterly summaries for cases that involve “well-known” complications. The FDA claims that this policy allowed the agency to “more efficiently review reports of well-known, well-understood adverse events.” However, the public was largely kept in the dark because this massive database was kept hidden, available only to the FDA – until now.

Read More

July 30, 2019

Whistleblower Appreciation Day reinforces nation’s commitment to justice, accountability

July 30 is National Whistleblower Appreciation Day, commemorating the signing of our country’s first whistleblower law in 1778. In the midst of the Revolutionary War, and faced with the dilemma of how to address the retaliatory dismissal and jailing of a pair of Navy sailors who had reported the mistreatment of enemy soldiers, our country’s earliest leaders made the critical choice to stand by these whistleblowers.

Read More

July 1, 2019

Youth vaping/e-cig use on the rise as states, cities push for protections

Vaping among today’s youth has reached crisis levels. If you have any doubt, look at the numbers. Even as traditional cigarette use continues to decline among high school students, vaping “increased alarmingly” between 2017 and 2018 by 78 percent, according to the FDA, to more than 3 million American teens. Shockingly, when accounting for middle schoolers, that number rises to more than 3.6 million.

Read More

June 14, 2019

Innovative class action approach in opioid litigation would create a beneficial and coordinated negotiating class on behalf of communities nationwide

With the volume of filed National Prescription Opiate Litigation cases (more than 1,800), which comprise just 10% of the nation’s counties and cities, a structure and process is needed to provide all counties and cities nationwide, filed and unfiled, with a collective and powerful voice in the litigation, and create a pre-established mechanism through which plaintiffs can consider and have a vote in potential settlements with defendants.

Read More